Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 20/20 | 0.48 |
| ▸ | CCNE1 | P24864 | 19/20 | 0.48 |
| ▸ | CCND1 | P24385 | 16/20 | 0.48 |
| ▸ | CDK6 | Q00534 | 15/20 | 0.48 |
| ▸ | CDK4 | P11802 | 6/20 | 0.48 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.48 |
| ▸ | CDK9 | P50750 | 4/20 | 0.48 |
| ▸ | CCND3 | P30281 | 2/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.40 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.40 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.40 |
| ▸ | CCND2 | P30279 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22860376 | 0.88 | CCNE1 (0.44) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL29640940 | 0.86 | CCND1 (0.60) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL19857389 | 0.86 | CCND1 (0.60) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL22860370 | 0.82 | CCND1 (0.49) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL29798894 | 0.81 | CCNE1 (0.65) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL19863588 | 0.81 | CCNE1 (0.65) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL22860647 | 0.80 | CCND1 (0.60) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL29508883 | 0.80 | CCND1 (0.60) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL29508885 | 0.80 | CCND1 (0.60) | CDK2CCNE1CCND1CDK6CDK4 | |
| SCHEMBL29507717 | 0.78 | CCND1 (0.42) | CDK2CCNE1CCND1CDK6CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3993802-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | Nuvation Bio Inc. (US) | 2022-05-11 | — | — | EP | disclosed |
| CN-114340634-A | Heterocyclic compounds as kinase inhibitors | 诺维逊生物股份有限公司 | 2022-04-12 | — | — | CN | disclosed |